Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (766) 766
Book / eBook (121) 121
Publication (118) 118
Newspaper Article (13) 13
Dissertation (12) 12
Book Chapter (11) 11
Conference Proceeding (8) 8
Patent (6) 6
Book Review (3) 3
Magazine Article (3) 3
Data Set (1) 1
Electronic Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (284) 284
humans (260) 260
female (151) 151
male (144) 144
animals (111) 111
analysis (101) 101
middle aged (89) 89
aged (79) 79
adult (78) 78
research (58) 58
mice (56) 56
cancer (49) 49
research article (49) 49
proteins (44) 44
medicine (42) 42
medicine & public health (42) 42
cell biology (38) 38
care and treatment (36) 36
oncology (36) 36
adolescent (35) 35
health aspects (35) 35
immunology (35) 35
child (34) 34
neurosciences (33) 33
biochemistry & molecular biology (32) 32
expression (31) 31
studies (31) 31
gene expression (30) 30
multidisciplinary sciences (29) 29
children (28) 28
science (28) 28
usage (28) 28
diagnosis (27) 27
risk factors (27) 27
treatment outcome (27) 27
patients (26) 26
surgery (26) 26
aged, 80 and over (25) 25
child, preschool (25) 25
therapy (25) 25
life sciences (24) 24
medicine, general & internal (24) 24
genetic aspects (23) 23
physiological aspects (23) 23
time factors (23) 23
biotechnology & applied microbiology (22) 22
enzymes (22) 22
inflammation (22) 22
mortality (22) 22
cell line, tumor (21) 21
genetics (21) 21
history (21) 21
plant sciences (21) 21
prognosis (21) 21
epidemiology (20) 20
flow cytometry (20) 20
in-vitro (20) 20
medical research (20) 20
rodents (20) 20
young adult (20) 20
brain (19) 19
cells (19) 19
chemistry, medicinal (19) 19
infectious diseases (19) 19
risk (19) 19
apoptosis (18) 18
biology (18) 18
derivatives (18) 18
disease (18) 18
genes (18) 18
mutation (18) 18
rats (18) 18
survival (18) 18
tumors (18) 18
chemistry, physical (17) 17
chemotherapy (17) 17
medicine, research & experimental (17) 17
metabolism (17) 17
microbiology (17) 17
pharmacology & pharmacy (17) 17
protein (17) 17
review (17) 17
article (16) 16
chemistry (16) 16
follow-up studies (16) 16
growth (16) 16
mice, inbred c57bl (16) 16
population (16) 16
stem cells (16) 16
antineoplastic agents - therapeutic use (15) 15
clinical neurology (15) 15
cohort studies (15) 15
dna (15) 15
pediatrics (15) 15
physiology (15) 15
prospective studies (15) 15
retrospective studies (15) 15
abridged index medicus (14) 14
chemistry, multidisciplinary (14) 14
disease models, animal (14) 14
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (52) 52
UTL at Downsview - May be requested (45) 45
Gerstein Science - Stacks (7) 7
Pontifical Inst. Mediaeval Studies - Library use only (6) 6
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
Art - Library use only (3) 3
St. Michael's College (John M. Kelly) - 2nd Floor (3) 3
UofT at Mississauga - Stacks (3) 3
Engineering & Comp. Sci. - Stacks (2) 2
Online Resources - Online (2) 2
Regis College - Stacks (2) 2
Robarts - Storage (2) 2
St. Augustine's Seminary - Stacks (2) 2
St. Michael's College (John M. Kelly) - 3rd Floor (2) 2
Trinity College (John W Graham) - Stacks (2) 2
UofT at Scarborough - Stacks (2) 2
Victoria University CRRS - Library use only (2) 2
Victoria University E.J. Pratt - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Mathematical Sciences - Stacks (1) 1
OISE - Stacks (1) 1
Physics - Stacks (1) 1
Pontifical Inst. Mediaeval Studies - Reference (1) 1
Royal Ontario Museum - Periodical Stacks (1) 1
St. Augustine's Seminary - Reference (1) 1
St. Michael's College (John M. Kelly) - Reference (1) 1
University College (Laidlaw) - Stacks (1) 1
UofT at Scarborough - Withdrawn (1) 1
Victoria University CRRS - Rare Book (1) 1
Victoria University E.J. Pratt - Northrop Frye (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (803) 803
Spanish (69) 69
Italian (58) 58
Portuguese (58) 58
German (9) 9
French (7) 7
Latin (6) 6
Catalan (1) 1
Danish (1) 1
Japanese (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Global football in the US market. The internationalization of FC Barcelona and its media coverage
by Ginesta, Xavier and de San Eugenio, Jordi and Bonet, Pau and Ferrer, Martí
Soccer and Society, ISSN 1466-0970, 2018, pp. 1 - 16
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text N‐glycan engineering of a plant‐produced anti‐CD20‐hIL‐2 immunocytokine significantly enhances its effector functions
by Marusic, Carla and Pioli, Claudio and Stelter, Szymon and Novelli, Flavia and Lonoce, Chiara and Morrocchi, Elena and Benvenuto, Eugenio and Salzano, Anna Maria and Scaloni, Andrea and Donini, Marcello
Biotechnology and Bioengineering, ISSN 0006-3592, 03/2018, Volume 115, Issue 3, pp. 565 - 576
Anti‐CD20 recombinant antibodies are among the most promising therapeutics for the treatment of B‐cell malignancies such as non‐Hodgkin lymphomas. We recently... 
complement‐dependent cytotoxicity | Fcγ receptors | N‐glycosylation | molecular farming | non‐hodgkin lymphoma | immunocytokine | N-glycosylation | complement-dependent cytotoxicity | non-hodgkin lymphoma | COMPLEMENT | HUMAN MONOCLONAL-ANTIBODY | RECEPTOR | GLYCOSYLATION | Fc gamma receptors | DEPENDENT CELLULAR CYTOTOXICITY | THERAPY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | RITUXIMAB | IN-VIVO | OPTIMIZATION | FC-GAMMA-RI | Recombinant Fusion Proteins - biosynthesis | Leukocytes, Mononuclear - metabolism | Recombinant Fusion Proteins - isolation & purification | Plants, Genetically Modified - genetics | Recombinant Fusion Proteins - pharmacology | Single-Chain Antibodies - pharmacology | Tobacco - metabolism | Humans | Polysaccharides - genetics | Polysaccharides - biosynthesis | Polysaccharides - pharmacology | Interleukin-2 - genetics | Plants, Genetically Modified - metabolism | Single-Chain Antibodies - genetics | Single-Chain Antibodies - isolation & purification | Polysaccharides - isolation & purification | Tobacco - genetics | Protein Engineering | Interleukin-2 - pharmacology | Recombinant Fusion Proteins - genetics | Single-Chain Antibodies - biosynthesis | Interleukin-2 - chemistry | Leukocytes, Mononuclear - cytology | Interleukin-2 - biosynthesis | Viral antibodies | Therapeutics | Antibodies | Lymphomas | Plants | Homeopathy | Materia medica and therapeutics | Binding | Toxicity | Interleukin | Rituximab | Cytotoxicity | Plants (organisms) | Glycosylation | Glycan | Xylose | Complement component C1q | Fc receptors | Biological effects | Interleukin 2 | Lymphocytes B | Monoclonal antibodies | Peripheral blood mononuclear cells | CD20 antigen | Sugar | Fucose | Recombinant | Antibody-dependent cell-mediated cytotoxicity
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Generation of site‐distinct N‐glycan variants for in vitro bioactivity testing
by Brühlmann, David and Vuillemin, Thomas and Satwekar, Abhijeet and Galano, Eugenio and Palmese, Angelo and D'Angelo, Alessandra and Manco, Zeynep and Souquet, Jonathan and Broly, Hervé and Sauer, Markus and Hemberger, Jürgen and Jordan, Martin
Biotechnology and Bioengineering, ISSN 0006-3592, 05/2019, Volume 116, Issue 5, pp. 1017 - 1028
Glycosylation, a critical product quality attribute, may affect the efficacy and safety of therapeutic proteins in vivo. Chinese hamster ovary fed‐batch cell... 
glycosylation | lycopeptide mapping | biological activity | media supplementation | HO cell culture | product quality | EFFECTOR FUNCTIONS | QUALITY | FC GLYCANS | MONOCLONAL-ANTIBODY | POSTTRANSLATIONAL MODIFICATIONS | NONFUCOSYLATED THERAPEUTIC ANTIBODIES | IMPACT | ELEVATED PCO | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | NEXT-GENERATION | Monoclonal antibodies | Enzymes | Binding | Cell culture | Biotechnology | Media (culture) | Dietary supplements | Mannose | Mapping | Glycosylation | Biodiversity | Cell surface | Biological activity | Glycan | Proteins | Heterogeneity | Biological effects | Polysaccharides | Affinity | Surface plasmon resonance | In vivo methods and tests | Supplementation | Product safety
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Complement Activation Determines the Therapeutic Activity of Rituximab In Vivo
by Di Gaetano, Nicola and Cittera, Elena and Nota, Rachele and Vecchi, Annunciata and Grieco, Valeria and Scanziani, Eugenio and Botto, Marina and Introna, Martino and Golay, Josee
The Journal of Immunology, ISSN 0022-1767, 08/2003, Volume 171, Issue 3, pp. 1581 - 1587
Rituximab is an anti-CD20 chimeric mAb effective for the treatment of B-NHL. It can lyse lymphoma cells in vitro through both G and Ab-dependent cellular... 
VITRO | CD20 | B-CELL LYMPHOMA | ANTI-CD20 MONOCLONAL-ANTIBODY | CHRONIC LYMPHOCYTIC-LEUKEMIA | RECEPTOR | NEUTROPHILS | IMMUNOLOGY | FC-GAMMA-RI | CYTOTOXICITY | T-CELLS | Neoplasm Transplantation | Humans | Complement C1q - physiology | Antibody-Dependent Cell Cytotoxicity - immunology | Cell Survival - genetics | Antibodies, Monoclonal - therapeutic use | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Lymphocyte Depletion | Lymphoma - therapy | Neoplasm Metastasis - immunology | Cell Division - immunology | Neoplasm Metastasis - prevention & control | Lymphoma - pathology | Tumor Cells, Cultured | Neutrophils - pathology | Cell Division - genetics | Antibodies, Monoclonal, Murine-Derived | Antibody-Dependent Cell Cytotoxicity - genetics | Neoplasm Metastasis - therapy | Mice, Inbred C57BL | Lymphoma - immunology | Rituximab | Complement C1q - genetics | Cell Survival - immunology | Mice, Knockout | Complement Pathway, Classical - immunology | Animals | Antibodies, Monoclonal - administration & dosage | Mice, Nude | Lymphoma - prevention & control | Mice | Complement C1q - deficiency | Complement Pathway, Classical - genetics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text An accessory protease inhibitor to increase the yield and quality of a tumour-targeting mAb in nicotiana benthamiana leaves
by Jutras, Philippe V and Marusic, Carla and Lonoce, Chiara and Deflers, Carole and Goulet, Marie-Claire and Benvenuto, Eugenio and Michaud, Dominique and Donini, Marcello
PLoS ONE, ISSN 1932-6203, 11/2016, Volume 11, Issue 11, pp. e0167086 - e0167086
The overall quality of recombinant IgG antibodies in plants is dramatically compromised by host endogenous proteases. Different approaches have been developed... 
TRANSIENT EXPRESSION | PLANT PROTEASES | PROTEOLYTIC DEGRADATION | TABACUM PLANTS | PROTECTION | RECOMBINANT PROTEINS | MULTIDISCIPLINARY SCIENCES | TOBACCO PLANTS | MONOCLONAL-ANTIBODY | HETEROLOGOUS PROTEINS | SUSPENSION CELLS | alpha 1-Antichymotrypsin - pharmacology | Humans | Tobacco - immunology | Neoplasms - therapy | Immunoglobulin G - immunology | Proteolysis | Plant Leaves - drug effects | Antibodies, Monoclonal - immunology | Peptide Hydrolases - metabolism | Recombinant Proteins - metabolism | Amino Acid Sequence | Lycopersicon esculentum - metabolism | Plants, Genetically Modified - genetics | Plants, Genetically Modified - drug effects | Tobacco - metabolism | Plants, Genetically Modified - immunology | Tobacco - drug effects | Peptide Hydrolases - chemistry | Plant Leaves - immunology | Plants, Genetically Modified - metabolism | Plant Leaves - genetics | Plant Leaves - metabolism | Recombinant Proteins - immunology | Neoplasms - immunology | Tobacco - genetics | Cysteine Proteinase Inhibitors - pharmacology | Antibodies, Monoclonal - metabolism | Cystatins - pharmacology | Immunoglobulin G - metabolism | Monoclonal antibodies | Physiological aspects | Nicotiana | Research | Protease inhibitors | Cystatin | Biotechnology | Peptides | Laboratories | Serine | Immunoglobulin G | Cysteine proteinase | Antibodies | Chains | Fragmentation | Proteins | Leaves | Plant tissues | Protease | Tomatoes | Enzyme-linked immunosorbent assay | Deoxyribonucleic acid--DNA | Recombinant | Immunoglobulins | Fragments | Proteinase inhibitors | Gene expression | Biological activity | Mitigation | Mutagenesis | Site-directed mutagenesis | West Nile virus | Protein expression | Serine proteinase | Tumors | Index Medicus | Deoxyribonucleic acid | DNA
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Plant production of anti‐β‐glucan antibodies for immunotherapy of fungal infections in humans
by Capodicasa, Cristina and Chiani, Paola and Bromuro, Carla and De Bernardis, Flavia and Catellani, Marcello and Palma, Angelina S and Liu, Yan and Feizi, Ten and Cassone, Antonio and Benvenuto, Eugenio and Torosantucci, Antonella
Plant Biotechnology Journal, ISSN 1467-7644, 09/2011, Volume 9, Issue 7, pp. 776 - 787
Summary There is an increasing interest in the development of therapeutic antibodies (Ab) to improve the control of fungal pathogens, but none of these... 
experimental candidiasis | chimeric antibodies | plant‐produced antibodies | antifungal therapy | carbohydrate microarrays | anti‐β‐glucan antibodies | Carbohydrate microarrays | Antifungal therapy | Anti-β-glucan antibodies | Experimental candidiasis | Chimeric antibodies | Plant-produced antibodies | PROTEIN | MANAGEMENT | PROTECTION | SPECIFICITY | RECEPTOR | MONOCLONAL-ANTIBODY | GLYCOSYLATION | PLANT SCIENCES | anti-beta-glucan antibodies | CANDIDA-ALBICANS | GENE | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | plant-produced antibodies | EXPRESSION | Recombinant Fusion Proteins - immunology | Cell Wall - immunology | Antibodies, Fungal - biosynthesis | Immunoglobulin Fc Fragments - metabolism | Antibodies, Monoclonal - biosynthesis | Humans | Cryptococcus neoformans - immunology | Mycoses - microbiology | Antibodies, Monoclonal - therapeutic use | Candida albicans - growth & development | Candidiasis - microbiology | Plantibodies - metabolism | Recombinant Fusion Proteins - metabolism | Tobacco - immunology | Single-Chain Antibodies - metabolism | Single-Chain Antibodies - genetics | Immunotherapy | Antibodies, Fungal - genetics | Mycoses - therapy | Candida albicans - physiology | Female | Models, Animal | beta-Glucans - immunology | Antibodies, Monoclonal - immunology | Cell Line | Rats | Plantibodies - immunology | Antigens, Fungal - immunology | Antibodies, Fungal - immunology | Candida albicans - immunology | Cell Adhesion - immunology | Plantibodies - therapeutic use | Antibodies, Monoclonal - genetics | beta-Glucans - metabolism | Animals | Immunoglobulin G - genetics | Plantibodies - genetics | Antibodies, Fungal - therapeutic use | Plant Leaves - genetics | Plant Leaves - metabolism | Tobacco - genetics | Aspergillus fumigatus - immunology | Candidiasis - therapy | Mice | Immunoglobulin Fc Fragments - genetics | Immunoglobulin G - metabolism
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text The Use of Football as a Country Branding Strategy. Case Study
: Qatar and the Catalan Sports Press
by Ginesta, Xavier and de San Eugenio, Jordi
Communication & Sport, ISSN 2167-4795, 9/2014, Volume 2, Issue 3, pp. 225 - 241
The main objective of this article is to analyse the sport place branding strategy of Qatar, a Persian Gulf country that is using the income from the... 
place branding | FC Barcelona | Qatar | HOSPITALITY, LEISURE, SPORT & TOURISM | Catalan sports press | public diplomacy | COMMUNICATION | AL-JAZEERA ENGLISH
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Production of an active anti‐ CD 20‐ hIL ‐2 immunocytokine in N icotiana benthamiana
by Carla Marusic and Flavia Novelli and Anna M. Salzano and Andrea Scaloni and Eugenio Benvenuto and Claudio Pioli and Marcello Donini
Plant Biotechnology Journal, ISSN 1467-7644, 01/2016, Volume 14, Issue 1, pp. 240 - 251
Anti‐CD20 murine or chimeric antibodies (Abs) have been used to treat non‐Hodgkin lymphomas (NHLs) and other diseases characterized by overactive or... 
Cell proliferation | Flow cytometry | Therapy | Accessibility | Toxicity | Protein purification | Interleukin | Antibodies | Cytotoxicity | Assaying | Degradation | Leaves | Engineering | Functional anatomy | Interleukin 2 | Affinity chromatography | Peripheral blood mononuclear cells | Recombinant | Antibody-dependent cell-mediated cytotoxicity | Binding | Plants (botany) | Sodium lauryl sulfate | Degradation products | Filtration | Purification | Cytokines | Rituximab | Glycosylation | Regression analysis | Patients | Chromatography | Biological activity | Flow | Diseases | Fc receptors | Cytometry | Lymphocytes B | Monoclonal antibodies | CD20 antigen | Gel filtration | Affinity | Lymphomas | Tumors | Integrity | B-cell lymphoma
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. La construcción de la marca 'Qatar' a partir del deporte: 'sports place branding' y prensa deportiva catalana
by De San Eugenio Vela, Jordi and Ginesta Portet, Xavier
Estudios Sobre el Mensaje Periodistico, ISSN 1134-1629, 2013, Volume 19, Issue 1, pp. 533 - 550
FC Barcelona | Public diplomacy | Sports press | Qatar | Place branding
Journal Article
Details down arrow
10. Full Text Immunoglobulin G fragment C receptor polymorphisms and KRAS mutations: Are they useful biomarkers of clinical outcome in advanced colorectal cancer treated with anti‐EGFR‐based therapy?
by Paez, David and Paré, Laia and Espinosa, Iñigo and Salazar, Juliana and Del Rio, Elisabeth and Barnadas, Agustí and Marcuello, Eugenio and Baiget, Montserrat
Cancer Science, ISSN 1347-9032, 09/2010, Volume 101, Issue 9, pp. 2048 - 2053
KRAS mutations have been identified as a strong predictor of resistance to anti‐epidermal growth factor receptor (EGFR) therapies. Besides inhibiting the EGFR... 
SURVIVAL | TRIAL | GROWTH-FACTOR-RECEPTOR | K-RAS | ONCOLOGY | CETUXIMAB PLUS IRINOTECAN | PHASE-II | CARCINOMA | SINGLE-AGENT CETUXIMAB | CHEMOTHERAPY | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Colorectal Neoplasms - genetics | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Antibodies, Monoclonal, Humanized | Receptors, IgG - genetics | Colorectal Neoplasms - drug therapy | Aged, 80 and over | Adult | Camptothecin - administration & dosage | Female | Cetuximab | Skin - pathology | Camptothecin - analogs & derivatives | Camptothecin - adverse effects | Receptor, Epidermal Growth Factor - immunology | Camptothecin - therapeutic use | Gene Frequency | Kaplan-Meier Estimate | Genotype | Proto-Oncogene Proteins - genetics | Treatment Outcome | Polymorphism, Genetic | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Biomarkers, Tumor - genetics | Mutation | Colorectal Neoplasms - pathology | Skin - drug effects | Care and treatment | Dermatology | Patient outcomes | Oncology, Experimental | Immunoglobulin G | Colorectal cancer | Dermatologic agents | Metastasis | Research | Risk factors | Fc receptors | Phosphoproteins | Formulae, receipts, prescriptions | Monoclonal antibodies | Genetic aspects | Biological markers | Cancer | Statistical analysis | Epidermal growth factor receptors | Toxicity | biomarkers | Effector cells | Growth factor receptors | Regression analysis | Multivariate analysis | Survival | K-Ras protein | Metastases | DNA | Antitumor activity | genomics | Skin | Antibody-dependent cell-mediated cytotoxicity | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants
by Zhou, Bin and Lu, Yuan and Hajifathalian, Kaveh and Bentham, James and Di Cesare, Mariachiara and Danaei, Goodarz and Bixby, Honor and Cowan, Melanie J and Ali, Mohammed K and Taddei, Cristina and Lo, Wei-Cheng and Reis-Santos, Barbara and Stevens, Gretchen A and Riley, Leanne M and Miranda, J. Jaime and Bjerregaard, Peter and Rivera, Juan A and Fouad, Heba M and Ma, Guansheng and Mbanya, Jean Claude N and McGarvey, Stephen T and Mohan, Viswanathan and Onat, Altan and Pilav, Aida and Ramachanan, Ambady and Romdhane, Habiba Ben and Paciorek, Christopher J and Bennett, James E and Ezzati, Majid and Abdeen, Ziad A and Abdul Kadir, Khalid and Abu-Rmeileh, Niveen M and Acosta-Cazares, Benjamin and Adams, Robert and Aekplakorn, Wichai and Aguilar-Salinas, Carlos A and Agyemang, Charles and Ahmadvand, Alireza and Al-Othman, Amani Rashed and Alkerwi, Ala'a and Amouyel, Philippe and Amuzu, Antoinette and Andersen, Lars Bo and Anderssen, Sigmund A and Anjana, Ranjit Mohan and Aounallah-Skhiri, Hajer and Brewster, Lizzy M and Snijder, Marieke B and Stronks, Karien and van Valkengoed, Irene G. M and NCD Risk Factor Collaboration and NCD Risk Factor Collaboration (NCD-RisC) and Umeå universitet
Lancet, ISSN 0140-6736, 2016, Volume 387, Issue 10027, pp. 1513 - 1530
Background One of the global targets for non-communicable diseases is to halt, by 2025, the rise in the age-standardised adult prevalence of diabetes at its... 
UNITED-STATES | HEALTH EXAMINATION SURVEYS | MIDDLE-INCOME COUNTRIES | LIFE-STYLE INTERVENTION | MEDICINE, GENERAL & INTERNAL | RISK-FACTORS | CARDIOVASCULAR-DISEASE | IMPAIRED GLUCOSE-TOLERANCE | FOLLOW-UP | PREVALENCE | SCIENTIFIC STATEMENT | Diabetes Mellitus - blood | Hypoglycemic Agents - therapeutic use | Age Distribution | Prevalence | Global Health | Developing Countries - statistics & numerical data | Humans | Diabetes Mellitus - drug therapy | Cost of Illness | Male | Incidence | Health Surveys | Diabetes Mellitus - epidemiology | Age of Onset | Bayes Theorem | Sex Distribution | Adult | Female | Blood Glucose - metabolism | Insulin - therapeutic use | Research Report - standards | Diabetics | Analysis | VDP | Medisinske Fag: 700 | Klinisk medisinske fag: 750 | Clinical medical disciplines: 750 | Medical disciplines: 700 | Clinical Medicine | Medical and Health Sciences | Endokrinologi och diabetes | Klinisk medicin | Medicin och hälsovetenskap | Endocrinology and Diabetes | HNE Voeding en Gezondheid in de Levenscyclus | Wereldvoeding | VLAG | Chair Nutrition and Health over the Lifecourse | Global Nutrition | HNE Nutrition and Health over the Lifecourse
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Trends in adult body-mass index in 200 countries from 1975 to 2014: A pooled analysis of 1698 population-based measurement studies with 19.2 million participants
by Di Cesare, Mariachiara and Bentham, James and Stevens, Gretchen A and Zhou, Bin and Danaei, Goodarz and Lu, Yuan and Bixby, Honor and Cowan, Melanie J and Riley, Leanne M and Hajifathalian, Kaveh and Fortunato, Léa and Taddei, Cristina and Bennett, James E and Ikeda, Nayu and Khang, Young-Ho and Kyobutungi, Catherine and Laxmaiah, Avula and Li, Yanping and Lin, Hsien-Ho and Miranda, J. Jaime and Mostafa, Aya and Turley, Maria L and Paciorek, Christopher J and Gunter, Marc and Ezzati, Majid and Abdeen, Ziad A and Hamid, Zargar Abdul and Abu-Rmeileh, Niveen M and Acosta-Cazares, Benjamin and Adams, Robert and Aekplakorn, Wichai and Aguilar-Salinas, Carlos A and Ahmadvand, Alireza and Ahrens, Wolfgang and Ali, Mohamed M and Alkerwi, Ala'a and Alvarez-Pedrerol, Mar and Aly, Eman and Amouyel, Philippe and Amuzu, Antoinette and Andersen, Lars Bo and Anderssen, Sigmund A and Andrade, Dolores S and Anjana, Ranjit Mohan and Aounallah-Skhiri, Hajer and Ariansen, Inger and Aris, Tahir and Arlappa, Nimmathota and Arveiler, Dominique and Assah, Felix K and Avdicová, Mária and Azizi, Fereidoun and Babu, Bontha V and Balakrishna, Nagalla and Bandosz, Piotr and Banegas, José R and Barbagallo, Carlo M and Barceló, Alberto and Barkat, Amina and Barros, Mauro V and Bata, Iqbal and Batieha, Anwar M and Batista, Rosangela L and Baur, Louise A and Beaglehole, Robert and Romdhane, Habiba Ben and Benet, Mikhail and Bernabe-Ortiz, Antonio and Bernotiene, Gailute and Bettiol, Heloisa and Bhagyalaxmi, Aroor and Bharadwaj, Sumit and Bhargava, Santosh K and Bhatti, Zaid and Bhutta, Zulfiqar A and Bi, HongSheng and Bi, Yufang and Bjerregaard, Peter and Bjertness, Espen and Bjertness, Marius B and Björkelund, Cecilia and Blake, Margaret and Blokstra, Anneke and Bo, Simona and Bobak, Martin and Boddy, Lynne M and Boehm, Bernhard O and Boeing, Heiner and Boissonnet, Carlos P and Bongard, Vanina and Bovet, Pascal and Braeckman, Lutgart and Bragt, Marjolijn C.E and Brajkovich, Imperia and Branca, Francesco and Breckenkamp, Juergen and Brenner, Hermann and Brewster, Lizzy M and Brian, Garry R and Bruno, Graziella and ... and NCD Risk Factor Collaboration NCD and Medicinska fakulteten and Institutionen för folkhälsa och klinisk medicin and Kardiologi and Umeå universitet
The Lancet, ISSN 0140-6736, 04/2016, Volume 387, Issue 10026, pp. 1377 - 1396
Background Underweight and severe and morbid obesity are associated with highly elevated risks of adverse health outcomes. We estimated trends in mean... 
MORTALITY | MEDICINE, GENERAL & INTERNAL | OBESITY | RISK-FACTORS | INCOME | BIAS | OVERWEIGHT | EPIDEMIC | ASSOCIATION | CHILDREN | Measurement | Body mass index | Adults | Analysis | Hälsovetenskaper | Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi | Medical and Health Sciences | Medicin och hälsovetenskap | Public Health, Global Health, Social Medicine and Epidemiology | Health Sciences
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights